デフォルト表紙
市場調査レポート
商品コード
1442868

ウェアラブルインジェクター市場:世界の業界分析、規模、シェア、成長、動向、および予測、2023年~2031年

Wearable Injectors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 190 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ウェアラブルインジェクター市場:世界の業界分析、規模、シェア、成長、動向、および予測、2023年~2031年
出版日: 2024年01月30日
発行: Transparency Market Research
ページ情報: 英文 190 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ウェアラブルインジェクター市場 - レポートの範囲

世界のウェアラブルインジェクター市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。レポートは、世界のウェアラブルインジェクター市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。レポートは、2023年から2031年までの世界のウェアラブルインジェクター市場の複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ウェアラブルインジェクター市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のウェアラブルインジェクター市場の競合情勢を詳しく掘り下げています。世界のウェアラブルインジェクター市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のウェアラブルインジェクター市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017~2031年

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場の分析と予測:タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:タイプ別、2017年~2031年
    • オンボディ
    • オフボディ
  • 市場魅力度分析:タイプ別

第7章 世界市場の分析と予測:用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:用途別、2017年~2031年
    • 腫瘍学
    • 糖尿病
    • 自己免疫疾患
    • 心血管疾患
    • 感染症
    • その他
  • 市場魅力分析:用途別

第8章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:エンドユーザー別、2017年~2031年
    • 病院
    • クリニック
    • ホームケア環境
    • その他
  • 市場魅力分析:用途別

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2017年~2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析:地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場プレーヤー- 競争マトリックス(企業の階層および規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • BD
    • F. Hoffmann-La Roche Ltd.
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Ypsomed AG
    • West Pharmaceutical Services, Inc.
    • CeQur Corporation
    • Debiotech SA
    • Sensile Medical AG(Gerresheimer AG)
    • United Therapeutics Corporation
図表

List of Tables

  • Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Wearable Injectors Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Wearable Injectors Market Revenue (US$ Mn), by Type, 2022
  • Figure 03: Global Wearable Injectors Market Value Share, by Type, 2022
  • Figure 04: Global Wearable Injectors Market Revenue (US$ Mn), by Application, 2022
  • Figure 05: Global Wearable Injectors Market Value Share, by Application, 2022
  • Figure 06: Global Wearable Injectors Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Wearable Injectors Market Value Share, by End-user, 2022
  • Figure 08: Global Wearable Injectors Market Value Share, by Region, 2022
  • Figure 09: Global Wearable Injectors Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 11: Global Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 12: Global Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 13: Global Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 14: Global Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 15: Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Wearable Injectors Market Value Share Analysis, by Region, 2022-2031
  • Figure 17: Global Wearable Injectors Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Wearable Injectors Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Wearable Injectors Market Value Share Analysis, by Country, 2022-2031
  • Figure 21: North America Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 22: North America Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 23: North America Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 24: North America Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 25: North America Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 26: North America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 31: Europe Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 32: Europe Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Europe Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 34: Europe Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: Europe Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Asia Pacific Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 40: Asia Pacific Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 41: Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 43: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 44: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Latin America Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 49: Latin America Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 50: Latin America Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Latin America Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 52: Latin America Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 53: Latin America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 57: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Type, 2022-2031
  • Figure 58: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Application, 2022-2031
  • Figure 59: Middle East & Africa Wearable Injectors Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 61: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 62: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL41969

Wearable Injectors Market - Scope of Report

TMR's report on the global wearable injectors market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global wearable injectors market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global wearable injectors market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the wearable injectors market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global wearable injectors market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global wearable injectors market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global wearable injectors market.

The report delves into the competitive landscape of the global wearable injectors market. Key players operating in the global wearable injectors market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global wearable injectors market profiled in this report.

Key Questions Answered in Global wearable injectors Market Report:

  • What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
  • What are the opportunities in the global wearable injectors market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Wearable Injectors Market - Research Objectives and Research Approach

The comprehensive report on the global wearable injectors market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global wearable injectors market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global wearable injectors market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Wearable Injectors Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Wearable Injectors Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Wearable Injectors Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. On-body Wearable Injectors
    • 6.3.2. Off-body Wearable Injectors
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Wearable Injectors Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Oncology
    • 7.3.2. Diabetes
    • 7.3.3. Autoimmune Disorders
    • 7.3.4. Cardiovascular Diseases
    • 7.3.5. Infectious Diseases
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Wearable Injectors Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Home Care Settings
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Wearable Injectors Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Wearable Injectors Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Type, 2017-2031
    • 10.3.1. On-body Wearable Injectors
    • 10.3.2. Off-body Wearable Injectors
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Oncology
    • 10.4.2. Diabetes
    • 10.4.3. Autoimmune Disorders
    • 10.4.4. Cardiovascular Diseases
    • 10.4.5. Infectious Diseases
    • 10.4.6. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals
    • 10.5.2. Clinics
    • 10.5.3. Home Care Settings
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Type
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Wearable Injectors Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. On-body Wearable Injectors
    • 11.3.2. Off-body Wearable Injectors
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Oncology
    • 11.4.2. Diabetes
    • 11.4.3. Autoimmune Disorders
    • 11.4.4. Cardiovascular Diseases
    • 11.4.5. Infectious Diseases
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Home Care Settings
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Wearable Injectors Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. On-body Wearable Injectors
    • 12.3.2. Off-body Wearable Injectors
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Oncology
    • 12.4.2. Diabetes
    • 12.4.3. Autoimmune Disorders
    • 12.4.4. Cardiovascular Diseases
    • 12.4.5. Infectious Diseases
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Home Care Settings
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Wearable Injectors Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. On-body Wearable Injectors
    • 13.3.2. Off-body Wearable Injectors
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Oncology
    • 13.4.2. Diabetes
    • 13.4.3. Autoimmune Disorders
    • 13.4.4. Cardiovascular Diseases
    • 13.4.5. Infectious Diseases
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Home Care Settings
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Wearable Injectors Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. On-body Wearable Injectors
    • 14.3.2. Off-body Wearable Injectors
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Oncology
    • 14.4.2. Diabetes
    • 14.4.3. Autoimmune Disorders
    • 14.4.4. Cardiovascular Diseases
    • 14.4.5. Infectious Diseases
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Clinics
    • 14.5.3. Home Care Settings
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. BD
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. F. Hoffmann-La Roche Ltd.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Tandem Diabetes Care, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Insulet Corporation
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Ypsomed AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. West Pharmaceutical Services, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. CeQur Corporation
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Debiotech S.A.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Sensile Medical AG (Gerresheimer AG)
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. United Therapeutics Corporation
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview